HomeBusinessHealthcare Industry Stock NewsPCE Data Lower Than Expected, NVO Falls on New Obesity Drug, AFRM Upgraded

PCE Data Lower Than Expected, NVO Falls on New Obesity Drug, AFRM Upgraded

Jenny Horne joins the Futures show with live reaction to the latest PCE inflation data. November rate rose just 0.1% from October, but on an annual basis checked in at 2.4% On the stock front, Novo Nordisk (NVO) slid sharply after disappointing clinical data for its new obesity drug CagriSema. And, Affirm (AFRM) got a bullish call from the analyst community.

Futures

20 Dec 2024

SHARE

ON AIR
7:00 pm
Gamma On
replay
12:00 am
Gamma On
REPLAY
12:30 am
Gamma On
REPLAY
1:00 am
Gamma On
REPLAY
1:30 am
Gamma On
REPLAY
2:30 am
Gamma On
REPLAY
3:00 am
Gamma On
REPLAY
3:30 am
Gamma On
REPLAY
4:00 am
Gamma On
REPLAY
5:00 am
Gamma On
REPLAY
6:00 am
Gamma On
REPLAY
education
7:00 am
Inside the Mind of a Trader
REPLAY
education
7:30 am
Inside the Mind of a Trader
REPLAY
education
8:00 am
Inside the Mind of a Trader
REPLAY
8:30 am
Market Overtime
REPLAY
9:00 am
Gamma On
REPLAY
9:30 am
Gamma On
REPLAY
10:00 am
Gamma On
REPLAY
10:30 am
Gamma On
REPLAY
11:30 am
Gamma On
REPLAY
12:00 pm
Gamma On
REPLAY
12:30 pm
Gamma On
REPLAY
1:00 pm
Gamma On
REPLAY
2:00 pm
Gamma On
REPLAY
3:00 pm
Gamma On
REPLAY
education
4:00 pm
Your First Trade
REPLAY
education
4:30 pm
Your First Trade
REPLAY
education
5:00 pm
Your First Trade
REPLAY
education
5:30 pm
Your First Trade
REPLAY
education
6:00 pm
Your First Trade
REPLAY
6:30 pm
Market Overtime
REPLAY
ON AIR
7:00 pm
Gamma On
REPLAY
8:00 pm
Gamma On
REPLAY
9:00 pm
Trading 360
REPLAY
10:00 pm
Fast Market
REPLAY
11:00 pm
Next Gen Investing
REPLAY

Get the Market Minute

Daily insights for every investor